29960sek
0,3 %
Date:2026-03-09Time:18:00:00Latest report:Q4-2025List:Large CapTicker:BIOA B
Market Cap:26 580 msekEnterprise Value:24 434 msekNet Sales:1 999 msekEarnings:1 022 msekEmployees:0ISIN:SE0010323311

Ratios

10-year key figure history for BioArctic turnover, profit, dividend, equity, PE and PB.

Pre
Pre

Stockprice

Price movement for BioArctic with index and moving average MA50 and MA200.

Stockprice:299,60
MA50:318,96
MA200:270,70
Price/MA200:10,7 %
RSI (14):43,5
Price/MA50:-6,1 %

Description

BioArctic is a biopharmaceutical company focused on developing new treatments that address the causes of neurodegenerative diseases. Examples of diseases include Alzheimer's and Parkinson's. A large part of the research is carried out in collaboration with researchers at universities and hospitals. BioArctic was founded in 2003 and is headquartered in Stockholm.

Biotechnology